Cisplatin enhances the cytotoxicity of fast neutrons in a murine lymphoma cell line1,2

• Published in: Canadian journal of physiology and pharmacology Vol. 82; no. 2; p. 140
• Main Authors: Fischer, B, Benzina, S, Ganansia-Leymarie, V, Denis, J M
• Format: Journal Article
• Language: English
• Published: Ottawa Canadian Science Publishing NRC Research Press 01.02.2004
• Subjects: Apoptosis; Cancer; Cells; Chemotherapy; Cytotoxicity; Lymphoma; Neutrons; Radiation therapy
• ISSN: 0008-4212

The utilization of high linear energy transfer (LET) radiations, such as fast neutrons or carbon ions (hadrontherapy), offers promising perspectives in radiotherapy. While it is well known that by combining radiotherapy and chemotherapy, important therapeutic advantages can be obtained to cure cancer, there have been, so far, very few investigations on the effects of treatments combining an irradiation with high-LET particles and cancer drugs. The present study was therefore undertaken to examine the effects of exposure to 65 MeV fast neutrons combined with cisplatin in a murine T cell lymphoma (RDM4) in vitro. The cells were irradiated at doses ranging from 2 to 8 Gy without or with addition of cisplatin shortly before the irradiation, at concentrations between 0.3 and 12.5 micro M. These treatments were applied concomitantly. Proliferation and apoptosis were assessed at different time intervals thereafter. The combination of irradiation with cisplatin was found to be more cytotoxic than either treatment alone. Furthermore, the cytotoxicity induced by this cotreatment resulted not only from apoptosis but also from other forms of cell death.